Results 31 to 40 of about 23,251 (236)
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. [PDF]
, 2012 Alopecia areata (AA), an autoimmune disease affecting anagen stage hair follicles, is associated with polymorphisms in immune-related genes and with decreased number of CD4+ CD25+ T regulatory cells (Treg).
Conteduca, Giuseppina
core +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Post-Partum Pituitary Insufficiency and Livedo Reticularis Presenting a Diagnostic Challenge in a Resource Limited Setting in Tanzania: A Case Report, Clinical Discussion and Brief Review of Existing Literature. [PDF]
, 2012 Pituitary disorders following pregnancy are an important yet under reported clinical entity in the developing world. Conversely, post partum panhypopituitarism has a more devastating impact on women in such settings due to high fertility rates, poor ...
A Cénac +27 more
core +3 more sources
Autoimmunity: Alopecia Areata [PDF]
Journal of Investigative Dermatology Symposium Proceedings, 2004 Strong direct and indirect evidence supports an autoimmune etiology for alopecia areata. T lymphocytes that have been shown to be oligoclonal and autoreactive are predominantly present in the peribulbar inflammatory infiltrate. Alopecia areata frequently occurs in association with other autoimmune diseases, such as thyroiditis and vitiligo, and ...
Hordinsky, Maria, Ericson, Marna
openaire +2 more sources
SAGE Open Medical Case Reports, 2023 Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Leah A Johnston +2 more
doaj +1 more source
Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy [PDF]
, 2016 We present a follow-up case report of a 33-year-old lady with juvenile onset arthritis who developed halo naevi while on treatment with tocilizumab. This case report describes the development of halo naevi, vitiligo and diffuse alopecia areata associated
Emery, P, Goodfield, M, Nadesalingam, K
core +1 more source
Acta Dermato-Venereologica, 2018 The development of androgenetic alopecia is associated with a risk of developing cardiovascular diseases, but the association of alopecia areata with cardiovascular diseases in humans is largely unexplored.
Eddy Hsi Wang +7 more
doaj +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang +5 more
doaj +1 more source
Estudio del manejo del estrés en pacientes acometidos por alopecia areata [PDF]
, 2009 Alopecia areata is a common dermatological disorder characterized by the rapid loss of hair in single or multiple patches. Hair loss is often on the scalp, but can also occur in other areas of the body.
Andreoli, Sergio Baxter +2 more
core +2 more sources
Seminars in Cutaneous Medicine and Surgery, 2015 There is neither a cure for alopecia areata (AA) nor any universally proven therapy that induces and sustains remission in patients afflicted with this autoimmune disease. AA is characterized as a nonscarring alopecia which affects children and adults.
Maria, Hordinsky, Ana Lucia, Junqueira
openaire +2 more sources